日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers.

新型临床前患者来源肺癌模型揭示抑制 HER3 和 MTOR 信号传导是 NRG1 融合阳性癌症的治疗策略

期刊:Journal of Thoracic Oncology
影响因子:20.8
doi:10.1016/j.jtho.2021.03.013
Odintsov Igor, Mattar Marissa S, Lui Allan J W, Offin Michael, Kurzatkowski Christopher, Delasos Lukas, Khodos Inna, Asher Marina, Daly Robert M, Rekhtman Natasha, de Stanchina Elisa, Ganji Gopinath, Ladanyi Marc, Somwar Romel
信号转导
肺癌
mTOR
肿瘤免疫
发表日期：2021
文献求助 收藏

Activation of KRAS Mediates Resistance to Targeted Therapy in MET Exon 14-mutant Non-small Cell Lung Cancer

KRAS激活介导MET 14号外显子突变型非小细胞肺癌对靶向治疗的耐药性

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-18-1640
Suzawa, Ken; Offin, Michael; Lu, Daniel; Kurzatkowski, Christopher; Vojnic, Morana; Smith, Roger S; Sabari, Joshua K; Tai, Huichun; Mattar, Marissa; Khodos, Inna; de Stanchina, Elisa; Rudin, Charles M; Kris, Mark G; Arcila, Maria E; Lockwood, William W; Drilon, Alexander; Ladanyi, Marc; Somwar, Romel
肺癌
MET
RAS
肿瘤
细胞生物学
肿瘤免疫
发表日期：2019
文献求助 收藏